Blood test screening for older adults
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial is screening people over 30 to find a protein in the blood called M protein, which can be a sign of certain blood conditions. If you have it, the study will follow you over time to learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years old or older.
- You are willing to give a blood sample and be part of the screening.
- You have never been diagnosed with a blood cancer or related B-cell or plasma cell disorder.
- You have not previously donated a sample that could not be tested properly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is screening for a condition called monoclonal gammopathy (abnormal proteins in the blood) using a new testing method. It is for people who are already having certain blood tests as part of their medical care or routine checkup.
This study is looking for adults at Zhujiang Hospital to test a new, highly sensitive method for detecting a protein called M protein in the blood. It helps doctors understand how common this protein is in different patients.
This trial screens first-degree relatives of people with multiple myeloma to check for early signs of the disease before symptoms. It may help doctors understand risk in families and find problems sooner if they occur.
This study looks at stored blood (serum) samples to see whether a lab test called MALDI-TOF mass spectrometry can help analyze multiple myeloma proteins. If you have multiple myeloma (or are a healthy matched control), your existing lab samples may be used for testing.
This study screens for MGUS, a precursor to certain blood cancers, in people who are Black or African American, or who have a close relative with a plasma cell disorder. If MGUS is found, you may be invited to continue in the study to monitor your health.
This study compares the gut bacteria of healthy adults (age 45+) with those who have a blood condition called monoclonal gammopathy. The goal is to see if gut bacteria patterns differ between the two groups.
Hear when a new Monoclonal Gammopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.